International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 8

Issue Published : 88

Article Submitted : 8769

Article Published : 4490

Total Authors : 11663

Total Reviewer : 551

Total Countries : 86

Indexing Partner


This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Evaluate the current prescription practice in newly diagnosed hypertensive patients; Treatment comparison with ISH 2020 Guidelines
Authors Name: Dr. Srijana Tamang , Dr. Luai Fahd Mohammad Alhetari , Dr. Balakeshwa Ramaiah , Dr. Prashant Kumar Sah
Download E-Certificate: Download
Author Reg. ID:
Published Paper Id: IJRTI2301017
Published In: Volume 8 Issue 1, January-2023
Abstract: Background: Hypertension is a very common medical problem worldwide. It is under-recognized and poorly treated. There is scope for significant improvement in hypertension therapy since only one-third of hypertension in India is diagnosed, of which only one-third is well treated and well controlled. Objective: The main objective of this study is to evaluate the current prescription practice of antihypertensive drugs in newly diagnosed hypertensive patients and to determine whether the prescription pattern is in adherence with ISH 2020 guidelines for the management of hypertension. Method: A prospective observational study was carried out for six months in a tertiary care hospital across the medical and cardiology services. Result: A total of 73 prescriptions were analyzed. Our results revealed that 54.80% were male while 45.20% were female, of which 49 (67.1%), 10 (13.7%), 6 (8.2%), 5 (6.8%) patients were receiving one, two, three and four anti-hypertensive drugs, respectively. Only 3 patients were on non-pharmacological treatment. In our study out of a total of 61 (83.56%), patients received essential standard care and 12 (16.43%) patients received optimal standard care, among which the majority, 64 (87.67%) patients achieved the targeted BP control and 9 (12.32%) didn't achieve the target BP. The most commonly prescribed anti-hypertensive drugs, whether in mono or combination regimens, were CCBs (amlodipine, cilnidipine), followed by ARBs (telmisartan, valsartan), diuretics (hydrochlorothiazide, torasemide, furosemide, mannitol), β-blockers (atenolol, bisoprolol, metoprolol), and ACE inhibitors (ramipril, enalapril). The mean systolic blood pressure Mean±SD of SBP/DBP in the final and first visit was 129.98±13.13/84.30±9.45 mmHg and 154.12±13.21/92.72±14.08 mmHg, respectively. A significant reduction (p<0.0001) in systolic and diastolic blood pressure was observed. Conclusion: The CCBs (Cilnidipine) and ARBs (Telmisartan) were the drugs of choice for hypertensive patients as a single drug and combination drug therapy. As per the International Society of Hypertension (ISH), 2020 guidelines, the majority of the subjects have achieved targeted BP goals. Our results reveal that the prescription practice of anti-hypertensive medication and adherence to guidelines is optimal at the study site.
Keywords: Newly diagnosed hypertension, prescription practice, antihypertensive, ISH
Cite Article: "Evaluate the current prescription practice in newly diagnosed hypertensive patients; Treatment comparison with ISH 2020 Guidelines", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 1, page no.95 - 108, January-2023, Available :http://www.ijrti.org/papers/IJRTI2301017.pdf
Downloads: 000214
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2301017
Registration ID:185057
Published In: Volume 8 Issue 1, January-2023
DOI (Digital Object Identifier):
Page No: 95 - 108
Country: Bengaluru, Karnataka, India
Research Area: Health Science 
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2301017
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2301017
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)

Providing A digital object identifier by DOI.ONE
How to Get DOI?


Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300


Indexing Partner